Journal of Leukocyte Biology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yin, L.
Right arrow Articles by Rudd, C. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yin, L.
Right arrow Articles by Rudd, C. E.
(Journal of Leukocyte Biology. 2003;73:178-182.)
© 2003 by Society for Leukocyte Biology

Short cytoplasmic SDYMNM segment of CD28 is sufficient to convert CTLA-4 to a positive signaling receptor

Li Yin*,{dagger}, Helga Schneider*,{dagger},{ddagger} and Christopher E. Rudd*,{ddagger},§

* Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, and Departments of
{dagger} Medicine and
§ Pathology, Harvard Medical School, Boston, Massachusetts; and
{ddagger} Department of Haematology, Imperial College of Science, Technology and Medicine, London, United Kingdom

Correspondence: Christopher E. Rudd, Imperial College of Science, Technology and Medicine, Department of Haematolgy, Division of Investigative Science, Faculty of Medicine, Hammersmith Hospital Campus, Du Cane Road, London, W12 ONN, UK. E-mail: c.rudd{at}ic.ac.uk

CD28 and cytotoxic T-lymphocyte antigen (CTLA)-4 are key coreceptors on the surface of T cells that have opposing effects on T cell activation. Although CD28 enhances proliferation, CTLA-4 markedly inhibits the activation process. These opposing roles are particularly surprising given the structural similarity of the cytoplasmic residues of the two receptors. These include the related CD28SDYMNM and CTLA-4GVYVKM motifs. In this study, we have directly addressed whether these related motifs may play different roles in the activation process by swapping the CTLA-4GVYVKM motif with the CD28SDYMNM motif. Remarkably, stable transfectants of the T cell hybridoma DC27.10 showed that substitution of CTLA-4GVYVKM was sufficient to convert CTLA-4 from a negative signaling coreceptor to a positive CD28-like coreceptor. CD28SDYMNM is therefore sufficient to convey positive signals within CTLA-4. These results demonstrate that CD28SDYMNM and CTLA-4GVYVKM motifs contain sufficient information to distinguish positive versus negative coreceptor signaling in T cells.

Key Words: coreceptor • phosphatidylinositol 3-kinase




This article has been cited by other articles:


Home page
J. Immunol.Home page
K. M. Dennehy, F. Elias, S.-Y. Na, K.-D. Fischer, T. Hunig, and F. Luhder
Mitogenic CD28 Signals Require the Exchange Factor Vav1 to Enhance TCR Signaling at the SLP-76-Vav-Itk Signalosome
J. Immunol., February 1, 2007; 178(3): 1363 - 1371.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Madrenas, L. A. Chau, W. A. Teft, P. W. Wu, J. Jussif, M. Kasaian, B. M. Carreno, and V. Ling
Conversion of CTLA-4 from Inhibitor to Activator of T Cells with a Bispecific Tandem Single-Chain Fv Ligand
J. Immunol., May 15, 2004; 172(10): 5948 - 5956.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the Society for Leukocyte Biology.